Vectura Group Forum

N1Singer put out a note this morning on it... "The merger between Skyepharma and Vectura has created a global leader in the development of therapeutic respiratory products, with strong global partners and broad development capability across multiple formulation platforms, drug classes and delivery forms. In this report we outline the company’s three strongest valuation drivers, a selection of high-potential development programmes and the financial outlook for the enlarged group." taken from Research Tree

200.10 a short glimpse of the bright future which is ahead of us!

Translated into plain english: severe asthma patient use besides inhaled cortico steroids (ics) also orally cortico steroids (ocs). ocs usually have quite severe side effects (whereas ics have much lower side effects. there it is always good for asthma patients who require ocs to reduce the ocs dose while maintaining there asthma status. at least to my knowledge there is no medication available today which can reduce ocs dose.

Welcome to the new Vectura Group stream forum! Messages posted in the Vectura Group stream will be logged here for posterity.

Invesco increase their holding to over 11%